Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
Hebei Zhongshiyou Central Hospital, Langfang, Hebei Luzhou Center for Disease Control and Prevention, Luzhou, Sichuan